Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-053549
Filing Date
2026-08-05
Accepted
2026-08-05 17:20:44
Documents
66
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vir-20260630.htm   iXBRL 10-Q 1358658
2 EX-10.1 a20260630-q2ex101xsanofi_v.htm EX-10.1 12657
3 EX-31.1 a20260630-q210qex311.htm EX-31.1 10826
4 EX-31.2 a20260630-q210qex312.htm EX-31.2 10798
5 EX-32.1 a20260630-q210qex321.htm EX-32.1 8091
  Complete submission text file 0001628280-26-053549.txt   6626027

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20260630.xsd EX-101.SCH 48134
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vir-20260630_cal.xml EX-101.CAL 62524
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vir-20260630_def.xml EX-101.DEF 256176
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20260630_lab.xml EX-101.LAB 577685
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20260630_pre.xml EX-101.PRE 396133
70 EXTRACTED XBRL INSTANCE DOCUMENT vir-20260630_htm.xml XML 786747
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39083 | Film No.: 261244898
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)